Sana Biotechnology, Inc.

NASDAQ:SANA

1.99 (USD) • At close May 23, 2025
Bedrijfsnaam Sana Biotechnology, Inc.
Symbool SANA
Munteenheid USD
Prijs 1.99
Beurswaarde 448,854,450
Dividendpercentage 0%
52-weken bereik 1.26 - 8.28
Industrie Biotechnology
Sector Healthcare
CEO Dr. Steven D. Harr M.D.
Website https://www.sana.com

An error occurred while fetching data.

Over Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295

Vergelijkbare Aandelen

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

44 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

5.81 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

9.85 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

14.57 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.26 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

9.71 USD

National Research Corporation logo

National Research Corporation

NRC

13.59 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

5.64 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

0.33 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)